Hepatitis C infection: eligibility for antiviral therapies

Background Current treatments of chronic hepatitis C virus (HCV) are effective, but expensive and susceptible to induce significant side effects. Objectives To evaluate the proportion of HCV patients who are eligible for a treatment. Methods In a database comprising 1726 viraemic HCV patients, the files of 299 patients who presented to the same hepatologist for an initial appointment between 1996 and 2003 were reviewed. Results Patients' characteristics were age 43.1 +/- 15.6 years, 53% male and 92% Caucasian. The main risk factors were transfusion (43%) and drug use (22%). Genotypes were mostly genotype 1 (66%), genotype 3 (12%) and genotype 2 (10%). These characteristics were not different from those of the whole series of 1726 patients. A total of 176 patients (59%) were not treated, the reasons for non-treatment being medical contraindications (34%), non-compliance (25%) and normal transaminases (24%). In addition, 17% of patients declined therapy despite being considered as eligible, mainly due to fear of adverse events. Medical contraindications were psychiatric (27%), age (22%), end-stage liver disease (15%), willingness for pregnancy (13%), cardiac contraindication (7%) and others (16%). Only 123 patients (41%) were treated. A sustained viral response was observed in 41%. The treatment was interrupted in 16% for adverse events. Conclusions The majority of HCV patients are not eligible for treatment. This implies that, with current therapies, only 17% of patients referred for chronic HCV become sustained responders. Some modifications of guidelines could extend the rate of treatment (patients with normal transaminases), but an important barrier remains the patients' and the doctors' fear of adverse events

Single strontium Rydberg ion confined in a Paul trap

Trapped Rydberg ions are a promising new system for quantum information processing. They have the potential to join the precise quantum operations of trapped ions and the strong, long-range interactions between Rydberg atoms. Combining the two systems is not at all straightforward. Rydberg atoms are severely affected by electric fields which may cause Stark shifts and field ionization, while electric fields are used to trap ions. Thus, a thorough understanding of the physical properties of Rydberg ions due to the trapping electric fields is essential for future applications. Here we report the observation of two fundamental trap effects. First, we investigate the interaction of the Rydberg electron with the trapping electric quadrupole fields which leads to Floquet sidebands in the excitation spectra. Second, we report on the modified trapping potential in the Rydberg state compared to the ground state which results from the strong polarizability of the Rydberg ion. By controlling both effects we observe resonance lines close to their natural linewidth demonstrating an unprecedented level of control of this novel quantum platform

Poly(2-dimethylamino ethylmethacrylate)-Based Polymers To Camouflage Red Blood Cell Antigens

peer reviewedPoly(2-dimethylamino-ethylmethacrylate) (PDMAEMA) is a cationic polymer when dissolved in a 7.4 pH fluid. Owing to its ionic nature, this polycation interacts with the negatively charged cell membrane surface of red blood cells (RBCs). The electrostatic self-assembly of PDMAEMA on RBCs membrane can be employed for inducing the formation of a polymeric shield camouflaging blood group antigens on RBCs as a valuable strategy for developing “universal RBCs” for blood transfusion. The purpose of this research was to evaluate the camouflaging ability of PDMAEMA homopolymers and PDMAEMA-copoly(nethylene glycol) copolymers differing in molecular weight and architecture. Surprisingly, the PDMAEMAs caused a partially masking, no masking, and sensitization of the same RBCs population. The MW and architecture of the polymers as well as temperature of PDMAEMA-RBCs treatment influenced the results observed. Herein, the very particular reactivity of PDMAEMAs and RBCs is analyzed and discussed

Hepatitis C of genotype 2: the role of medical invasive exams.

BACKGROUND AND AIM: Hepatitis C virus genotype 2 is the third in order of frequency in Belgium. The aim of this study was to better define the genotype 2 carriers' epidemiology characteristics. METHODS: In a database comprising 1726 viremic hepatitis C virus patient from the south part of Belgium, the files of 98 genotype 2 carriers were reviewed. RESULTS: There was a strong association between genotype 2 and the mode of transmission. The rate of contamination by invasive medical exams was very high (23%), and statistically different from the one of the others genotypes. Eligibility for antiviral therapies and the rate of sustained viral response were high. CONCLUSION: HCV genotype 2 was highly associated with transmission by invasive medical exams.Peer reviewe

Linkage analyses in Caribbean Hispanic families identify novel loci associated with familial late-onset Alzheimer's disease

INTRODUCTION: We performed linkage analyses in Caribbean Hispanic families with multiple late-onset Alzheimer's disease (LOAD) cases to identify regions that may contain disease causative variants. METHODS: We selected 67 LOAD families to perform genome-wide linkage scan. Analysis of the linked regions was repeated using the entire sample of 282 families. Validated chromosomal regions were analyzed using joint linkage and association. RESULTS: We identified 26 regions linked to LOAD (HLOD ≥3.6). We validated 13 of the regions (HLOD ≥2.5) using the entire family sample. The strongest signal was at 11q12.3 (rs2232932: HLODmax = 4.7, Pjoint = 6.6 × 10(-6)), a locus located ∼2 Mb upstream of the membrane-spanning 4A gene cluster. We additionally identified a locus at 7p14.3 (rs10255835: HLODmax = 4.9, Pjoint = 1.2 × 10(-5)), a region harboring genes associated with the nervous system (GARS, GHRHR, and NEUROD6). DISCUSSION: Future sequencing efforts should focus on these regions because they may harbor familial LOAD causative mutations

Single strontium Rydberg ion confined in a Paul trap

Trapped Rydberg ions are a promising new system for quantum information processing. They have the potential to join the precise quantum operations of trapped ions and the strong, long-range interactions between Rydberg atoms. Combining the two systems is not at all straightforward. Rydberg atoms are severely affected by electric fields which may cause Stark shifts and field ionization, while electric fields are used to trap ions. Thus, a thorough understanding of the physical properties of Rydberg ions due to the trapping electric fields is essential for future applications. Here we report the observation of two fundamental trap effects. First, we investigate the interaction of the Rydberg electron with the trapping electric quadrupole fields which leads to Floquet sidebands in the excitation spectra. Second, we report on the modified trapping potential in the Rydberg state compared to the ground state which results from the strong polarizability of the Rydberg ion. By controlling both effects we observe resonance lines close to their natural linewidth demonstrating an unprecedented level of control of this novel quantum platform

EMbaRC - A European Consortium of Microbial Resource Centres for Science & lnnovation

EMbaRC is an EU project funded under the Seventh Framework Programme, Research lnfrastructures action. lt aims to improve, coordinate and validate microbial Biological Resource Centres (BRC) delivery to European and lnternational researchers from both public and private sectors. Apart from the networking and research activities, EMbaRC offers EU-supported grants for Trans-national Access opportunities. Scientists who carry out research in Europe or Associated Countries can use EMbaRC infrastructures to support part of their research project. ln this presentation, the main achievements of the first year will be summarized. Networking activities allow i) an estimation of overlapping/uniqueness between the consortium holdings, ii) a deep analysis of strain deposit after publication, iii) a review of the training offered by the consortium in the collection management and associated tools (identification, data management, etc.), iv) an harmonisation of the quality manual, v) a first draft for a biosecurity code, and vi) establish the basis of a common strategy to increase the sustainability of BRCs. Joint Research activities focused in particular on storage of recalcitrant strains, DNA storage and species identification by new methods like mass spectrometry ... ln parallel, success stories are being gathered to support the idea that microbial collections contribute to the bioeconomy. Such achievements can be a way to increase the sustainability of collections, and some of them will be presented